Especially for people already spending significant amounts on GLP-1 medications
no efficacy, therapeutic, or human-use claim is made for IDUNs product
ELI LILLY Q1 REVENUES: Revenue in the first quarter of 2026 rose by 56% to $19.8 billion, largely driven by higher volumes, with some offset from lower realized prices for Mounjaro and Zepbound
Zepbound costs The company that makes Zepbound, Eli Lilly, says the list price is about $1,060 for a four-week supply
The effects of ashwagandha on thyroid function appear to be dose-dependent and can vary based on an individuals thyroid status
Additional services: Consultation, follow-up, and aftercare products